Neuroscience 2005 Abstract
| Presentation Number: | 1027.19 |
|---|---|
| Abstract Title: | Cannabinoid 1 receptor antagonist treatment reverses behavioral sensitization to nicotine in adolescent rats with novelty-seeking phenotype. |
| Authors: |
Isgor, C.*1
; Maharaj, S.1
; Hall, P.1
; Ma, Z.1
; Tao, R.1
1Department of Biomedical Science, Florida Atlantic Univ., Boca Raton, FL |
| Primary Theme and Topics |
Disorders of the Nervous System - Addiction and Drugs of Abuse -- Nicotine |
| Secondary Theme and Topics | Disorders of the Nervous System<br />- Addiction and Drugs of Abuse<br />-- Neuroplasticity and addiction |
| Session: |
1027. Nicotine: Reinforcement and Behavior Poster |
| Presentation Time: | Wednesday, November 16, 2005 3:00 PM-4:00 PM |
| Location: | Washington Convention Center - Hall A-C, Board # UU94 |
| Keywords: | nicotine, cannabinoids, hippocampus, mossy fiber |
There are normally-occurring neurobiological differences between individuals which are critical for relapse to nicotine. The sensation-seeking trait is one such individual difference with a rat correlate of the novelty-seeking phenotype. We prescreened rats at weaning to identify rats that ranked in locomotor reactivity to a novel environment at the top third of the population (high responders; HRs, n = 18), middle third of the population (intermediary responders; IRs), and the lowest third of the population (low responders; LRs). Adolescent rats (postnatal days 24-40) received a behavioral sensitization to nicotine regimen (nicotine every fourth day for four times; 0.7 mg/kg; s.c.). Locomotor reactivity to novelty is measured for 90 min following injection. After the last injection, rats went through abstinence for 1 wk during when they received saline or therapeutic drug administration. For therapeutics, rats were injected with bupropion (days 1, 4 and 7 of withdrawal; 40 mg/kg; s.c.) or with a CB1 receptor antagonist, AM251 (5 mg/kg; i.p.). At the end of withdrawal, rats received a low dose of nicotine challenge (0.35 mg/kg) and tested for locomotor reactivity for the expression of behavioral sensitization. Animals were sacrificed and brains were harvested and sectioned. Hippocampal mossy fibres were stained using the Timm’s method and mossy fibre terminal field volumes were quantitated using contemporary stereology. Adolescent HRs had an augmented expression of behavioral sensitization to nicotine which was reversed with AM251 but not bupropion treatment. Repeated nicotine exposure during adolescence resulted in changes in HR hippocampal mossy fibre terminal field size, which responded to the AM251 treatment. These results suggest that individuals who use nicotine as part of a novelty-seeking repertoire may benefit most from CB1 receptor-targeting drugs.
Supported by endowment from Charles E. Schmidt Foundation
Sample Citation:
[Authors]. [Abstract Title]. Program No. XXX.XX. 2005 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2005. Online.
Copyright © 2005-2026 Society for Neuroscience; all rights reserved. Permission to republish any abstract or part of any abstract in any form must be obtained in writing by SfN office prior to publication.